Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control

Abstract

Insights

Schizophrenia involves increased matrix metalloproteinase-9 (MMP-9) and oxidative stress markers like malondialdehyde (MDA), with reduced total antioxidant status (TAS). These factors correlate with each other but not directly with disease severity.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Schizophrenia pathogenesis involves synaptic plasticity deregulation and oxidative stress.
  • Matrix metalloproteinase-9 (MMP-9) regulates synaptic plasticity.
  • Malondialdehyde (MDA) indicates lipid peroxidation and is elevated in schizophrenia.

Purpose of the Study:

  • To assess serum levels of MMP-9, MDA, and total antioxidant status (TAS) in schizophrenia.
  • To investigate the association between MMP-9, MDA, TAS, and schizophrenia.

Main Methods:

  • Study included 40 schizophrenia cases and 40 controls.
  • Serum MMP-9, MDA, and TAS were measured.
  • Disease severity assessed using the Positive and Negative Syndrome Scale (PANSS).

Main Results:

  • Significantly higher MMP-9 and MDA levels in cases vs. controls.
  • Significantly lower TAS in cases vs. controls.
  • MMP-9 positively correlated with MDA and negatively with TAS; TAS correlated with symptom scores.

Conclusions:

  • MMP-9 and oxidative stress are elevated and interconnected in schizophrenia.
  • While TAS correlated with disease severity, MMP-9 and MDA did not show association with symptom severity.